StockData
ResMed Inc logo

ResMed Inc

RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 21/3011% below fair value
$242.61+4.76 (+2.00%)

Close on Nov 18, 2026Market cap $34.12BP/E 22.1Yield 0.99%

ResMed Americas Life Support Devices Revenue by Quarter

Americas Life Support Devices Revenue ($M) ($M)

Periods

ResMed Americas Life Support Devices Revenue: $0M in Q1 FY27, down 100.0% from a year earlier.

Latest, Q1 FY27
0
Period ended Sep 30, 2026 (CQ3 2026)
Change on a year earlier
-100.0%
9 in Q1 FY26
History
5 quarters
Since Q1 FY26
Sources
2
Documents cited below

Where the Q1 FY27 figure comes from

“|| Life Support Devices | — | 9 | (94 | ) | (94 | )”

Source: ResMed SEC Filing (0001193125-26-437783) ↗

Reported in ResMed Q1 FY2027 Form 8-K & Q4 FY26 / Q1 FY27 Earnings Presentations.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAmericas Life Support Devices Revenue ($M) ($M)Year on yearSource
Q1 FY27CQ3 2026Sep 30, 20260-100.0%ResMed SEC Filing (0001193125-26-437783) ↗
Q4 FY26CQ2 2026Jun 30, 20267–ResMed Q1 FY2027 Earnings Presentation (2026-10-29) ↗
Q3 FY26CQ1 2026Mar 31, 202611–ResMed Q1 FY2027 Earnings Presentation (2026-10-29) ↗
Q2 FY26CQ4 2025Dec 31, 202510–ResMed Q1 FY2027 Earnings Presentation (2026-10-29) ↗
Q1 FY26CQ3 2025Sep 30, 20259–ResMed SEC Filing (0001193125-26-437783) ↗

Breakdown

What makes up americas Life Support Devices Revenue

Cite this data

StockData. (2026). ResMed Americas Life Support Devices Revenue ($M), quarterly Q1 FY26–Q1 FY27 [Data set]. Compiled from ResMed SEC filings and investor materials. https://stockdatahq.com/stocks/rmd/kpis/dev-amer-ls-rev

See every metric in the ResMed KPI table. Data updated Nov 8, 2026.

See a number that looks wrong?